Despite advances in epilepsy pharmacotherapy around 30-40% of patients with epilepsy remain drug resistant; resective surgical treatment can be curative in a significant subset of these patients. 1, 2 For physicians outside of the field of epilepsy, identifying good candidates for epilepsy surgery can be very challenging and may lead to under-referral to specialists for surgical evaluation. The literature on surgical outcomes in patients with specific characteristics is focused on highly selected patients and typically considers only patients who undergo surgery and not those who are referred for surgical evaluation but are rejected as resective candidates, either before or after implantation. 3 Thus the available outcome data do not clearly reflect the early decision-making process or an intention-to-treat methodology. Unlike many other areas of medicine where staging systems and grading scales provide risk stratification and treatment success likelihoods, there is no simple tool for identifying an individual patient's likelihood of achieving seizure freedom from resective surgery. Such a tool could facilitate counseling and decision making for referring clinicians and for patients.
For most experienced epileptologists, there is an intuitive initial impression of whether a patient is a good candidate for resective epilepsy surgery at the time of initial evaluation based on knowledge of the literature, experience, and the patient's individual characteristics. For clinicians with less experience, who may be trying to counsel patients on why they should be referred to a comprehensive epilepsy center, this assessment is considerably more difficult to come by. To address this knowledge gap, we convened a consortium of experts in epilepsy surgery and epidemiology, for whom the need for a clear unifying system to evaluate and stratify surgical eligibility was acknowledged.
In addition to expert consensus, we performed a systematic literature review, to ensure we were addressing the most appropriate predictive factors for the scale. [3] [4] [5] [6] [7] [8] [9] [10] [11] Based on the systematic literature review and expert consensus, we developed a three-tier, empirically derived mathematical scale with five individual categories: magnetic resonance imaging (MRI), electroencephalography (EEG), concordance (between MRI and EEG), semiology, and intelligence quotient (IQ). The scale should appear intuitive to most epileptologists, as it basically codifies the characteristics that experts use reflexively to determine a patient's likelihood of a good surgical response (e.g., MRI findings, EEG, and others). The question was whether these items could be used to derive a mathematical score that would be predictive of outcome. In this manuscript, we present the initial validation of the scale.
The Epilepsy Surgery Grading Scale (ESGS) is intended to be utilized for patients who are drug resistant to assess their likelihood of proceeding to resective surgery and becoming seizure-free as a result.
Methods

Standard protocol approvals, registrations, and patient consents
This study was approved by the New York University Langone Medical Center (NYULMC) Institutional Review Board with a waiver of consent for inclusion.
Epilepsy Surgery Grading Scale derivation
Following the systematic review exercise, a meeting of experts in epilepsy and epidemiology was convened. Several archetypal patients were described that should fit into particular grades based on expert opinion. At the conclusion of this meeting, it was established that a scale would be created that would lead to three different grades and that the scale should stratify the archetypal patients correctly into those categories. The components of the ESGS were decided upon during this expert consensus process based on clinical relevance and the ability to obtain and classify the information reliably early in the epilepsy evaluation process.
As a result, the scoring system and cutoff ranges were driven by expert opinion based in part on the theoretical patient types described. The MRI, EEG, and concordance categories have a positive (additive) impact on the score, whereas semiology and IQ are subtractive (see Table 1 ). A total score of ≥7.5 is Grade 1; a score of ≤4.0 is Grade 3; and a score of >4.0 to <7.5 is Grade 2. The representative patients are summarized in Table 2 to give an idea of the practical application of the score to patient data.
Magnetic resonance imaging
The MRI category is composed of five subcategories: normal, unilateral mesial temporal sclerosis (MTS), other temporal lobe lesion, extratemporal lesion, and two or more potentially epileptogenic lesions. An epileptogenic lesion is
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• The ESGS may facilitate communication, decisionmaking, and early referral to a CEC, and inform patients and referring doctors to better manage expectations defined as a structural lesion that is causally or potentially related to epilepsy. 12 MRI diagnosis was based on neuroradiologists' reports or consensus impression if reviewed in multidisciplinary conference (MDC).
Electroencephalography
The EEG category is composed of five subcategories, and refers to the localization of interictal epileptiform discharges: normal (no interictal epileptiform abnormalities), unifocal temporal, unifocal extratemporal, bilateral independent or multifocal (temporal or extratemporal), and bisynchronous or generalized discharges. EEG findings were coded as unifocal, bilateral, multifocal, or generalized based on findings reported by the interpreting electroencephalographer. Discharges that were described as 90-100% unifocal (i.e., completely unifocal, or very rare contralateral discharges) were coded as unifocal.
This scale was designed to be used with the best source of interictal EEG data available. This might include multiple outpatient EEG studies or long-term monitoring. For this study, interictal data were utilized from the inpatient epilepsy monitoring unit stay.
Concordance
The concordance category refers to the relationship between the MRI and interictal EEG findings: concordant, partially concordant, and not concordant. For example, if the MRI has a left temporal lesion and the interictal EEG demonstrates only left temporal epileptiform discharges, the data would be considered concordant. If the MRI reveals a left frontal lesion and the EEG shows left hemispheric epileptiform discharges, the data would be partially concordant. If the MRI has a left temporal lesion and interictal EEG demonstrated bilateral temporal epileptiform discharges, the data would be partially concordant. The finding of bilateral homologous MRI abnormalities and bilateral homologous EEG abnormalities was defined as partially concordant; there is no way of determining which side is epileptogenic and amenable to resection. If either or both MRI or EEG were classified as normal, the concordance category would be nonconcordant. Table 2 illustrates representative Grade 1, 2, and 3 patients.
Semiology
The semiology category has two subcategories: focal motor onset seizure semiology or "other," which encompasses any other semiology or an unknown semiology. Focal motor onset seizures were defined as characterized by an initial symptom consisting of focal tonic or clonic activity, of which the patient was aware, as determined by chart review.
Intelligence quotient
The IQ category is composed of two subcategories: IQ score of ≥70 or unknown, or <70. IQ assessment was based on formal neuropsychological testing when available, or other documentation derived from the referring or treating physicians' clinical evaluation.
Study design
We collected clinical, demographic, and diagnostic data through chart review of all patients admitted to the NYULMC epilepsy monitoring unit for presurgical evaluation or presented in surgical multidisciplinary conference (MDC) at the NYU Comprehensive Epilepsy Center (CEC) from 1/1/2007 to 7/31/2008. We classified patients into Grade 1 (expected to be the most favorable candidates; most likely to proceed to resective epilepsy surgery and become seizure-free as a result), Grade 2 (intermediate candidates), and Grade 3 (least favorable candidates) using the ESGS. We then determined the outcomes for all patients including whether patients were presented in the MDC, whether they progressed to resective epilepsy surgery, and whether they were seizure-free following a resective procedure.
Patients
Inclusion criteria required that patients were admitted to the NYULMC epilepsy monitoring unit (EMU) for a presurgical evaluation or were presented for epilepsy surgery in the NYU MDC between 1/1/2007 and 7/31/2008. Mimicking the characteristics of most patients who would be referred for surgery, we required that patients had a diagnosis of focal epilepsy for ≥2 years, had failed ≥1 medication, and had ≥1 seizure in the 3 months prior to admission. This standard was chosen to encompass the larger range of potential presurgical patients. Although we recognize that this allows for inclusion of patients that have a higher likelihood of seizure freedom with another drug trial compared to the current definition, we used a broader designation, as many epileptologists may consider surgical treatment options while continuing second and third drug trials. Patients with known progressive neurodegenerative or medical disease (s), nonepileptic seizures, previous resective epilepsy surgery, or comorbid alcohol and/or drug addiction were excluded. Patients with known mixed epilepsy syndromes (partial and generalized epilepsy) were excluded, as patients with generalized epilepsy are not typically considered candidates for resective epilepsy surgery. Because children might have characteristics different from those of adults, we included only patients who were ≥18 years of age. The remaining patients failed to meet one or more of the inclusion criteria including the age range, primary diagnosis, and/or reason for admission. All subjects had at least one video-EEG admission confirming the diagnosis of epilepsy and at least one neuroimaging study (MRI preferred, computerized tomography [CT] scan when MRI was contraindicated). Patients were subsequently divided into three cohorts for analysis as follows:
Cohort 1: All patients who met eligibility criteria who were admitted to the EMU for a presurgical evaluation. This is the broadest group, as in many cases physicians had no data on seizure localization or interictal EEG; their surgical candidacy at that time is therefore unknown. Cohort 2: All patients presented in MDC conference. This is a more select group, as physicians at NYULMC typically only present patients who they believe are potential surgical candidates. Cohort 3: Patients who underwent resective surgery. This is the group that is typically assessed in studies evaluating characteristics of good surgical candidates.
Data abstraction and analysis
Data from all patients who met eligibility criteria were abstracted into a secure password-protected database with their demographic information, presurgical evaluation data including description of seizure semiology, MRI results, neuropsychological testing, prior EEG studies, and current and previous treatments. Calculation of the ESGS score was based on these evaluations. Statistical analyses were performed utilizing SPSS v 21 (IBM). Differences between grades were assessed utilizing analysis of variance (ANOVA) with subgroup analyses based on the Student's t-test.
Outcome assessment
The primary outcome was seizure freedom following resective surgery, defined as ≥12 months seizure-free.
Patients were classified as either seizure-free following resective surgery (Engel class I), not seizure-free following surgery (Engel class II-IV), or no surgery. 13 The secondary outcome was progression to surgery following presurgical evaluation. Outcomes were assessed at the study's conclusion (October 31, 2013), allowing sufficient time for surgery to occur and outcome to be measured.
Results
We identified 1,105 patients admitted to the NYU CEC epilepsy monitoring unit. There were an additional 102 patients who were presented in MDC at NYU during this period, totaling 1,207 patients. Of these, 407 patients met eligibility criteria. A total of 200 (49.1%) were presented in MDC and 113 (27.8%) proceeded to resective surgery. The mean duration of postresection follow-up was 5.0 years (median 5.2 years, range 1-7 years). Table 3 illustrates the types of resections of the patients across the grades. 
Discussion
This study is the first implementation of a novel grading scale in a large intention-to-treat population to establish its ability to stratify patients with drug-resistant epilepsy based on their chance of proceeding to resective epilepsy surgery and becoming seizure-free. The scale effectively stratified three different cohorts of patients derived from the intention-to-treat population into distinct groups. For two cohorts, all three groups had statistically different likelihoods of proceeding to resective epilepsy surgery and becoming seizure-free; for the third cohort (the cohort of only patients that proceeded to surgery), there was a difference between Grades 1 and 3 as well as between 2 and 3, but a significant difference was not seen between the two higher grades (Grades 1 and 2 ). These results demonstrate that, using basic information available during initial assessment, patients with drug-resistant epilepsy may be successfully stratified into clinically meaningful groups.
Virtually all areas of medicine make use of grading and staging tools to assess disease severity and response to treatment. Perhaps the best-developed and universally utilized tool is the Tumor Node Metastasis (TNM) staging system for cancer.
14 Within neurology and neurosurgery, the most relevant grading scale is the Spetzler-Martin Arteriovenous Malformation (AVM) Operative Risk Grading System. 15 This scale has been universally adopted, and has made a substantial difference in the management of AVM patients. As illustrated by these widely accepted grading systems, historically the best scales have been simple, easy to use, usually based on predictors selected by experts in the field, tested retroactively to analyze the reliability and consistency of the grading system, and subsequently validated in outcome studies. This study was a scale derivation study using prognosticators that were designated by extensive, systematic literature review and an expert panel, with retrospective analysis to test the predictive values of the system.
One of the goals of the ESGS was to utilize data that are part of the initial evaluation of patients with focal epilepsy. The components, along with the variables within each component, were chosen according to the existing surgical outcome literature and expert opinion. Interictal EEG data were selected over ictal, as there are data to support the use of interictal findings to determine candidacy for surgery 9, 10, 16, 17 and ictal EEG data are rarely available for patients early in the process because this typically requires admission to an epilepsy monitoring unit. The use of interictal data from video-EEG likely allowed for some patients to be more accurately graded (which may or may not change the final grade depending on the nature of the EEG findings) compared to only routine EEG studies where a normal study would more likely be captured. 18 Although a single routine EEG may have comparatively reduced sensitivity, serial routine EEG studies may increase detection of interictal epileptiform discharges by up to 59-82%; the detection increase on successive EEG recordings may be concordant with the increase observed in a single extended recording. 19 Unifocal interictal epileptiform discharges have been shown to be a predictor of ictal onsets and favorable postsurgical outcome in patients with temporal and extratemporal epilepsy, 9,10 whereas multifocal interictal discharges 5 and generalized discharges 20 have been associated with a poor postsurgical outcome. Epileptogenic lesions include gliosis, encephalomalacia, tumors, vascular anomalies, and MTS. 14 The positive predictive value of unilateral MTS and hippocampal atrophy on postsurgical outcome has been established. [21] [22] [23] Normal brain MRI findings [23] [24] [25] and the presence of multilobar brain lesions 26 are associated with persistent seizures postoperatively. The use of MRI and EEG concordance is supported by the general approach to epilepsy surgery that depends on the presentation of multiple concordant sources of data. 8, 11, 16, 27, 28 Low IQ has been suggested to be of negative predictive value and reflective of more diffuse brain pathology. 27, [29] [30] [31] Semiology may identify the symptomatogenic zone as a surrogate for the epileptogenic zone and may provide localization. A motor semiology suggests that the ictal-onset zone overlaps or is adjacent to eloquent cortex and therefore potentially nonresectable. 32 We initially considered other possible semiologic predictors such as sensory and visual auras, but found that the identification of these was unreliable, and that in preliminary analyses and within the existing literature, they did not have significant predictive effects. They were therefore eliminated from the final version of the grading scale.
Notably, just under half the patients admitted to the EMU as presurgical candidates were presented in MDC, and of those, only 56.5% proceeded to surgery. This demonstrates the dramatic bias that occurs in the literature by looking only at patients who ultimately make it to the operating table. Impressively, when looking at the patients about whom the least was known at the time of grading (Cohort 1), Grade 1 patients had a 61.5% chance of proceeding to surgery and those who underwent surgery had an 84.3% chance of seizure freedom as a result. Compare this to Grade 3, where only 14.7% underwent surgery, and of those who did, only 33.3% were seizure-free following surgery (Fig. 3) . This suggests that ESGS could be extremely useful for resource-poor areas, or to identify the most likely candidates for surgery in large populations where surgery is not currently performed. It is important to note that a relatively high rate of seizure freedom can be achieved in this group of patients after obtaining a full presurgical evaluation, thus demonstrating the importance of having all patients with drug-resistant epilepsy evaluated at a comprehensive epilepsy center. Although Grade 1 patients predominantly underwent temporal lobectomies, it is noteworthy that of the 36 cases of unilateral MTS, 30 were classified as Grade 1, and 6 were classified as Grade 2, with a total of 19 going on to becoming seizure-free. Patients with temporal lobe epilepsy and those with structural lesions are more likely than patients with extratemporal and nonlesional epilepsy to be considered optimal surgical candidates as supported by the literature, [3] [4] [5] [6] [7] [8] [9] [10] [11] 33, 34 and reflected by the ESGS. However, it is important to acknowledge that extratemporal lesional cases have the potential to be excellent candidates for resective surgery, but may often require additional confirmation of localization. Such cases would be initially classified as Grade 2, which ultimately possesses a good likelihood of achieving seizure freedom.
It is notable that even within the larger intention-totreat population, surgical treatment results in a similar or better likelihood than medical management of achieving seizure freedom. When examining only the patients who underwent surgery, a clear advantage over medical management 35, 36 is seen for all three ESGS grades. However, Grade 2 and 3 patients will likely require additional noninvasive evaluations such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), or magnetoencephalography (MEG), and some may be routed to nonresective treatment options. The data from this study do not identify a patient population that should be denied surgery or surgical evaluation based on these data (i.e., the ESGS Grade) alone.
An important benefit of the ESGS could be the introduction of a more uniform language among that would facilitate better epidemiology and tracking. Center-specific statistics could be derived for Grade 1, 2, and 3 patients and be compared to historical normative data to identify the impact of newer diagnostic treatments or resective approaches. This scale may serve as a tool to allow more uniform inclusion of patients in epilepsy surgery studies and studies targeting new diagnostic techniques.
There are limitations of this study. The first is that all the data derived from a single epilepsy center (NYU). For the scale to become universally accepted, it will have to be validated across centers where surgical work-up may differ. There was a large percentage of patients across all grades that did not proceed to presentation in MDC or epilepsy surgery despite the initial presurgical evaluation. However, the fact that the percent proceeding to surgery from Cohort 1 was substantially greater in Grade 1 (61.5%) vs. Grades 2 (26.1%) and 3 (14.7%), suggests that this was ultimately driven more by appropriateness for surgery than by psychosocial or financial factors. Recruitment of subjects from a tertiary epilepsy center may also result in bias for subjects with more refractory epilepsy, and as such, may not represent patients in a community setting. To better reflect a more typical setting, we excluded subjects who had failed prior epilepsy surgery, and those with primary brain malignancies, as these do not represent primary epilepsy surgeries. We utilized interictal data derived from long-term EEG monitoring in this study and recognize that this was more sensitive in recognizing epileptiform discharges and more likely to capture multifocal populations of epileptiform discharges. The ESGS focuses on seizure freedom resulting from epilepsy surgery and does not consider the potentially positive benefits and enhanced quality of life that may result from palliative surgery with significant improvement in seizure control even without achieving seizure freedom. Similarly, other quality of life assessments were not utilized. It is possible that a selection bias for patients that progress to surgery impacts the results seen in this study; MRI-negative patients are frequently considered to be more challenging surgical candidates and thus may be less likely to be taken to surgery. This could lead to apparent "confirmation" of that bias in a consecutive cohort of presurgical evaluations. Future prospective analyses examining subjects within grades may allow for further differentiation within these larger groups.
The primary goal of better identification of good candidates for epilepsy surgery with the ESGS (i.e., candidates with a high likelihood of seizure freedom) should not be misconstrued as a tool for identifying only selected patients that require referral to comprehensive epilepsy centers. The Canadian study for appropriateness for surgery for epilepsy (CASES) developed a tool to identify patients that would require referral to epilepsy centers, and this tool very clearly highlights that any patient with drug-resistant epilepsy should be referred to a comprehensive epilepsy center. 37, 38 The authors also echo the need recognized in the Institute of Medicine report for all patients with treatment-resistant epilepsy to be evaluated within an epilepsy center. 39 Rather, the scale may facilitate easier identification of patients, such as those with drug-resistant mesial temporal lobe or welllocalized lesional epilepsy, who may benefit from immediate referral to a comprehensive epilepsy center and early resective surgery. 40 The scale also distinguishes less optimal candidates who would benefit from additional noninvasive testing to augment presurgical planning, management, and prognostication. The scale is dynamic; a lower calculated grade as a result of, for example, a normal routine EEG or low resolution brain MRI would prompt repeat or supplementary investigation that better clarifies a patient's candidacy for curative surgery or initiate discussion of the benefits of palliative surgery. Although this study did not directly assess impact on communication and referral patterns, we believe that the common language provided by the ESGS will improve communication, assist decision making, and inform patients, families, and referring physicians to better manage expectations.
The ESGS is an effective stratification method for identifying three meaningful grades to assess the likelihood of achieving seizure freedom in patients undergoing presurgical evaluation. Given the potential variables in patient populations, the presurgical evaluation process, and surgical approaches, it will be important to further validate this instrument in other centers with both retrospective as well as prospective patient populations.
